Clinical Trial Update: Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the safety, tolerability, and potential efficacy of arbaclofen in individuals with 16p11.2 deletion syndrome; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 16p11 Deletion Syndrome

Drugs mentioned

• Arbaclofen (arbaclofen)

Snippet

Sponsor: Clinical Research Associates, LLC | Conditions: 16P11.2 Deletion Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING